COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Loar Holdings Inc. Reports Q2 2025 Record Results and Upward Revision to 2025 Outlook and Announces the Acquisition of Beadlight Ltd.
Loar Holdings Inc. reports record results in Q2 2025, upward guidance revision, Beadlight Ltd. acquisition, and credit agreement amendment. Strong sales and income growth -
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Blue Cap AG: Blue Cap sells subsidiary con-pearl GmbH to Inteplast Group Corporation and adjusts forecast for fiscal year 2025 due to transaction
Blue Cap AG sells subsidiary con-pearl GmbH to Inteplast Group, impacting fiscal year 2025 forecast. Adjusted revenue and EBITDA margin expectations due to transaction -
COMMUNIQUÉ DE PRESSE
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
Mainz Biomed receives Swiss regulatory approval to market ColoAlert®, a non-invasive colorectal cancer screening test, following partnership with a local laboratory. The test aims to improve participation rates in CRC screening programs -
COMMUNIQUÉ DE PRESSE
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl
Tharimmune, Inc. expands its intellectual property portfolio for TH-104, a transmucosal film, for broader indications with new patents. FDA positive feedback accelerates national security efforts -
